ENDO USA, Inc. Buprenorphine Hydrochloride, Injection, 0.3mg/mL recall: Crystallization; identified as Buprenorphine free base
Crystallization; identified as Buprenorphine free base
The hazard: Drug safety concern
A problem with this medicine prompted the recall. With prescriptions, the first move is a conversation rather than a decision.
What the notice says: Crystallization; identified as Buprenorphine free base
Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.
Recall details
- Recall number
- D-0527-2026
- Published
- May 20, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- ENDO USA, Inc.
- Product type
- Prescription & OTC drugs
- Units affected
- 34,293 vials
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
Products covered by this recall
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Check your product
The notice names 14 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 84132
- Exp 02
- 28
- 2027
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 02
- 28
- 2027
- 03
- 31
- 2027 — 34
- 293 vials
NDC number
On the carton and again on the bottle or blister label.
- 42023-179-05
Package size
Match the net weight or the piece count on the front of the pack.
- 0.3 mg
- 1 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Drug safety
ENDO USA, Inc. — A problem with this medicine prompted the recall. With prescriptions, the first move is a conversation rather than a decision.
- Check the lot number on your pack against the codes listed above.
- Keep the carton; the lot number is often printed only on the outer pack.
- Report side effects you think the product caused to FDA MedWatch.
- Do not stop a prescribed medicine on your own — speak to your prescriber or pharmacist first.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: ENDO USA, Inc. — 870 Parkdale Rd, Rochester, MI, 48307-1740
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was ENDO USA, Inc. prescription & otc drugs recalled?
Crystallization; identified as Buprenorphine free base Crystallization; identified as Buprenorphine free base
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 84132, Exp 02, 28; best-by date 02 or 28. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 7.5mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 2.5 mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 10 mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 5mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class III · 1+ years ago
Endo USA, Inc. Everolimus tablets 5mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility